Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
0.0%
operating margin TTM
0.0%
revenue TTM
9.36 Million
revenue per share TTM
0.07$
valuation ratios | |
|---|---|
| pe ratio | -7.80 |
| peg ratio | 0.26 |
| price to book ratio | 4.58 |
| price to sales ratio | 0.00 |
| enterprise value multiple | -9.52 |
| price fair value | 4.58 |
profitability ratios | |
|---|---|
| gross profit margin | 0.0% |
| operating profit margin | 0.0% |
| pretax profit margin | 0.0% |
| net profit margin | 0.0% |
| return on assets | -40.87% |
| return on equity | -67.22% |
| return on capital employed | -38.75% |
liquidity ratio | |
|---|---|
| current ratio | 9.25 |
| quick ratio | 9.25 |
| cash ratio | 6.61 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 5,475.85 |
| cash conversion cycle | -5,475.85 |
| receivables turnover | 0.00 |
| payables turnover | 0.07 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.20 |
| debt equity ratio | 0.29 |
| long term debt to capitalization | 0.21 |
| total debt to capitalization | 0.23 |
| interest coverage | -19.92 |
| cash flow to debt ratio | -1.21 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.08 |
| cash per share | 3.65 |
| operating cash flow per share | -1.08 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.21 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -4,178.22 |
Frequently Asked Questions
When was the last time Centessa Pharmaceuticals plc (NASDAQ:CNTA) reported earnings?
Centessa Pharmaceuticals plc (CNTA) published its most recent earnings results on 12-11-2024.
What is Centessa Pharmaceuticals plc's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Centessa Pharmaceuticals plc (NASDAQ:CNTA)'s trailing twelve months ROE is -67.22%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Centessa Pharmaceuticals plc (CNTA) currently has a ROA of -40.87%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CNTA's net profit margin stand at?
CNTA reported a profit margin of 0.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CNTA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 9.25 in the most recent quarter. The quick ratio stood at 9.25, with a Debt/Eq ratio of 0.29.